Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

McCann FE, Perocheau DP, Ruspi G, Blazek K, Davies ML, Feldmann M, Dean JL, Stoop AA, Williams RO.

Arthritis Rheumatol. 2014 Oct;66(10):2728-38. doi: 10.1002/art.38755.

PMID:
24965881
[PubMed - in process]
2.

IRF5 is a specific marker of inflammatory macrophages in vivo.

Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA.

Mediators Inflamm. 2013;2013:245804. doi: 10.1155/2013/245804. Epub 2013 Dec 23.

PMID:
24453413
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.

McCann FE, Palfreeman AC, Andrews M, Perocheau DP, Inglis JJ, Schafer P, Feldmann M, Williams RO, Brennan FM.

Arthritis Res Ther. 2010;12(3):R107. doi: 10.1186/ar3041. Epub 2010 Jun 2.

PMID:
20525198
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk